+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Vagus Nerve Stimulation"

From
From
From
From
From
From
From
North America Neuromodulation Procedures Outlook to 2025 - Product Thumbnail Image

North America Neuromodulation Procedures Outlook to 2025

  • Report
  • December 2018
  • 26 Pages
  • North America
From
Asia-Pacific Neuromodulation Procedures Outlook to 2025 - Product Thumbnail Image

Asia-Pacific Neuromodulation Procedures Outlook to 2025

  • Report
  • December 2018
  • 32 Pages
  • Asia Pacific
From
EU5 Neuromodulation Procedures Outlook to 2025 - Product Thumbnail Image

EU5 Neuromodulation Procedures Outlook to 2025

  • Report
  • December 2018
  • 32 Pages
  • Europe
From
Germany Neuromodulation Procedures Outlook to 2025 - Product Thumbnail Image

Germany Neuromodulation Procedures Outlook to 2025

  • Report
  • November 2018
  • 15 Pages
  • Germany
From
Loading Indicator

The Vagus Nerve Stimulation (VNS) market is a subset of the larger Neurology Devices market. VNS is a type of neuromodulation therapy used to treat a variety of neurological conditions, such as epilepsy, depression, and anxiety. It involves the use of an implanted device that sends electrical signals to the vagus nerve, which is located in the neck. The device is programmed to deliver electrical pulses at regular intervals, which can help reduce symptoms of the condition. VNS is a relatively new technology, and its use is growing as more research is conducted on its efficacy. The VNS market is highly competitive, with a number of companies offering devices and services. Some of the major players in the market include Medtronic, Cyberonics, NeuroPace, and LivaNova. These companies offer a range of products, from implantable devices to software and services. Additionally, there are a number of smaller companies that specialize in VNS technology, such as NeuroSigma, NeuroMetrix, and Stimwave Technologies. Show Less Read more